- Home
- BLRX vs CXAI Comparison
BLRX vs CXAI Comparison
Compare BLRX & CXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLRX | CXAI |
|---|---|---|
| Founded | 2003 | N/A |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.1M | 17.8M |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | BLRX | CXAI |
|---|---|---|
| Price | $3.33 | $0.38 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $19.00 | N/A |
| AVG Volume (30 Days) | 28.9K | ★ 2.7M |
| Earning Date | 11-24-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $12,735,000.00 | $5,222,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $70.21 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.30 | $0.36 |
| 52 Week High | $14.70 | $2.54 |
Technical Indicators
Market Signals| Indicator | BLRX | CXAI |
|---|---|---|
| Relative Strength Index (RSI) | 47.19 | 36.27 |
| Support Level | $3.14 | $0.36 |
| Resistance Level | $3.43 | $0.60 |
| Average True Range (ATR) | 0.22 | 0.06 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 26.70 | 6.00 |
Price Performance
Historical ComparisonAbout BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About CXAI CXApp Inc.
CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.